Huntington Bancshares' third-quarter 2026 report serves as an important checkpoint for investors following the bank's expansion into a larger regional player. With the recent acquisitions of Cadence and Veritex now contributing for a full quarter, this update offers a clearer view of integration progress, cost control, and revenue synergies. The numbers also provide broader insight into regional bank dynamics, including deposit pricing, loan demand, and credit quality in a higher-for-longer rate setting. Management's multi-year targets add another layer, signaling whether those ambitions look realistic from here.
HBAN posted GAAP net income of $721 million for the third quarter of 2026, or $0.33 per diluted share, compared with $686 million, or $0.33 per share, in the second quarter. Net income applicable to common shares totaled $680 million. Adjusted EPS, which strips out acquisition-related items, came in at $0.38 and matched consensus while slipping $0.01 sequentially.
Total revenue reached $2.791 billion, down slightly from $2.837 billion in the prior quarter but well above $2.134 billion a year earlier thanks to the full impact of the acquisitions. Net interest income climbed 1% sequentially to $2.069 billion, and net interest margin improved to 3.25% from 3.21%. Noninterest income fell 8% to $722 million, weighed down by softer capital markets fees and equity valuation adjustments, while noninterest expense declined 2% to $1.772 billion. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Capital metrics stayed solid, with a Common Equity Tier 1 ratio of 10.1% and a tangible common equity ratio of 6.9%. Tangible book value per share was $9.47. The company repurchased $100 million of common stock in the quarter, bringing year-to-date repurchases to $409 million.
Shares moved modestly higher in premarket trading after the release, as investors balanced the steady earnings beat on an adjusted basis and the constructive 2027 outlook against a modest revenue shortfall and lower noninterest income. Sentiment ahead of the report had been measured, with the stock near the bottom of its 52-week range and down year to date while the broader market advanced.
The reaction highlights two themes: clear earnings power and synergy delivery on one side, and questions around loan growth, fee income variability, and credit normalization on the other. Management's confidence in delivering more than 20% EPS growth by 2027 helped provide some reassurance, even as some near-term estimate revisions edged lower.
Management's 2027 guidance points to EPS of $1.75 to $1.83, more than 20% above 2025 levels, alongside a rise in return on tangible common equity to 17% to 18% and tangible book value growth above 10%. Achieving these targets will hinge on continued integration benefits, expense discipline, and growth in fee businesses such as payments, wealth management, and capital markets.
Near-term items worth monitoring include deposit pricing pressure, the bank's ability to protect net interest margin as rates evolve, and loan growth trends after average loans dipped slightly this quarter amid selective pullbacks in commercial real estate and certain consumer areas. Credit quality remains within guidance, though net charge-offs rose sequentially. Management expects no reserve release in 2027 and plans to build reserves with portfolio growth, a prudent approach that could limit near-term earnings. Capital return via buybacks is expected to continue through 2026 and 2027.
In my own research process, I often turn to Tickeron’s AI tools to cross-check patterns and peer comparisons after reviewing earnings releases like this one. The platform’s customizable filters help surface relevant signals quickly without replacing core fundamental work. For anyone tracking banks or broader market trends, it serves as a useful supplement to traditional analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Indicator for HBAN moved out of oversold territory on September 25, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 19 similar instances when the indicator left oversold territory. In 13 of the 19 cases the stock moved higher. This puts the odds of a move higher at 68%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on HBAN as a result. In 50 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
The Moving Average Convergence Divergence (MACD) for HBAN just turned positive on October 07, 2026. Looking at past instances where HBAN's MACD turned positive, the stock continued to rise in 30 of 45 cases over the following month. The odds of a continued upward trend are 67%.
Following a +3.22% 3-day Advance, the price is estimated to grow further. Considering data from situations where HBAN advanced for three days, in 174 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The 50-day moving average for HBAN moved below the 200-day moving average on October 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HBAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 61%.
HBAN broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HBAN entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 6 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. HBAN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock slightly worse than average.
The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.068) is normal, around the industry mean (1.246). P/E Ratio (11.909) is within average values for comparable stocks, (13.217). Projected Growth (PEG Ratio) (1.829) is also within normal values, averaging (1.190). Dividend Yield (0.039) settles around the average of (0.035) among similar stocks. P/S Ratio (2.863) is also within normal values, averaging (3.738).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
Industry RegionalBanks